Effect of Ciprofloxacin and Levofloxacin on the QT Interval: Is This a Significant “Clinical” Event?

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Southern medical journal (Birmingham, Ala. Print)

• Publication date

  2006-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.smj.0000197124.31174.7ePMID 16466123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A survey of health care practitioners’ knowledge of the QT interval

  2005cited by this paper
• What clinicians should know about the QT interval.

  2003cited by this paper
• Quinolones:

  2003cited by this paper
• Long QT syndrome: diagnosis and management.

  2002cited by this paper
• Torsades de Pointes Associated with Fluoroquinolones

  2002cited by this paper
• Cardiotoxicity of fluoroquinolones.

  2002cited by this paper
• Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin

  2001cited by this paper
• Fluoroquinolone Adverse Effects and Drug Interactions

  2001cited by this paper
• Evaluating the Risk of Cardiac Toxicity

  2001cited by this paper
• Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.

  2001cited by this paper
• Molecular biology and the prolonged QT syndromes.

  2001cited by this paper
• Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.

  2000cited by this paper
• The long QT syndromes: genetic basis and clinical implications.

  2000cited by this paper
• Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.

  2000cited by this paper
• Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.

  2000cited by this paper
• Risk of torsades de pointes with non-cardiac drugs

  2000cited by this paper
• Chemical cardioversion of atrial fibrillation with intravenous dofetilide.

  1995cited by this paper
• Prolonged QT interval syndromes.

  1986cited by this paper
• Prolonged QT-interval syndromes.

  1986cited by this paper
• Long QT: good, bad or indifferent?

  1984cited by this paper
• Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6.

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Hurst's the Heart

  1966cited by this paper

• The effect of oral ciprofloxacin at conventional doses on the QT interval in a tertiary outpatient setting

  2026cites this paper
• Preliminary human health risk assessment of antibiotic exposures in human waste handling occupations

  2024cites this paper
• Association Between Fluoroquinolones and Major Adverse Cardiovascular Events: A Systematic Review.

  2024cites this paper
• Drug Utilization Evaluation Study of Ciprofloxacin Use and Adverse Events Occurrence: Role of Community Pharmacists

  2023influential citation
• Serial electrocardiogram recordings revealed a high prevalence of QT interval prolongation in patients with tuberculosis receiving fluoroquinolones.

  2023cites this paper
• Fluoroquinolones: old drugs, putative new toxicities

  2022cites this paper
• Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review

  2022cites this paper
• Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation

  2021cites this paper
• Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019

  2021influential citation
• Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients

  2021cites this paper
• Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.

  2021cites this paper
• Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia: A Comparative Study.

  2020cites this paper
• High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam

  2020influential citation
• How to approach the QT interval in dogs - State of the heart: a review.

  2018cites this paper
• Évaluation des effets secondaires graves des traitements dans les infections ostéo-articulaires

  2017cites this paper
• Crohn ' s Disease : From an Anesthetist ’ s Perspective Beyazit Zencirci

  2017cites this paper
• Ciprofloxacin does not Prolong the QTc Interval: A Clinical Study in ICU Patients and Review of the Literature.

  2017cites this paper
• Cardiac arrest among patients with infections: causes, clinical practice and research implications.

  2017cites this paper
• Fluoroquinolones increase the risk of serious arrhythmias

  2017cites this paper
• Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study

  2016cites this paper
• Safety and Tolerability Profile of Second-Line Anti-Tuberculosis Medications

  2015cites this paper
• Weighing the adverse cardiac effects of fluoroquinolones: A risk perspective

  2015cites this paper
• Cardiac risks associated with antibiotics: azithromycin and levofloxacin

  2015cites this paper
• QTc prolongation and treatment of multidrug-resistant tuberculosis.

  2015cites this paper
• Cardiovascular Issues and the QT Interval

  2013cites this paper
• Crohn's Disease: From an Anesthetist’s Perspective

  2012cites this paper
• Ciprofl oxacin and the risk for cardiac arrhythmias: culprit delicti or watching bystander?

  2012cites this paper
• Ciprofloxacin Cardiotoxicity and Hepatotoxicity in Humans and Animals

  2012cites this paper
• Cardiovascular and metabolic safety profiles of the fluoroquinolones

  2012influential citation
• QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications

  2011cites this paper
• Adverse event reports : their role in detecting and preventing drug-drug interactions

  2011cites this paper
• In vitro assessing the risk of drug-induced cardiotoxicity by embryonic stem cell-based biosensor

  2011cites this paper
• Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.

  2010cites this paper
• Safety Profile of the Fluoroquinolones

  2010cites this paper
• Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature.

  2009cites this paper
• Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.

  2009cites this paper
• Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.

  2009cites this paper
• Ciprofloxacin-induced Q-T interval prolongation.

  2008cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2007cites this paper
• [QTc-prolonging drugs and the risk of sudden death].

  2007cites this paper
• Arrhythmias associated with fluoroquinolone therapy.

  2007cites this paper
• The use of fluoroquinolones in children

  2006cites this paper
• The use of fluoroquinolones in children: recent advances

  2006cites this paper
• Drug-induced QT prolongation.

  2006cites this paper
• Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy

  2006cites this paper